Total Payments
$211,787
2024 Payments
$77.87
Companies
30
Transactions
350
Medicare Patients
3,004
Medicare Billing
$398,628
Payment Breakdown by Category
Other$176,595 (83.4%)
Travel$26,171 (12.4%)
Food & Beverage$8,932 (4.2%)
Education$88.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $176,595 | 44 | 83.4% |
| Travel and Lodging | $26,171 | 92 | 12.4% |
| Food and Beverage | $8,932 | 212 | 4.2% |
| Education | $88.89 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $205,346 | 179 | $0 (2022) |
| Medtronic Vascular, Inc. | $1,617 | 19 | $0 (2020) |
| Acist Medical Systems, Inc. | $985.71 | 10 | $0 (2022) |
| HEARTFLOW, INC. | $919.75 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $905.12 | 22 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $318.12 | 19 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $251.95 | 15 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $219.56 | 15 | $0 (2023) |
| Amgen Inc. | $189.15 | 10 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $163.00 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $77.87 | 4 | HEARTFLOW, INC. ($24.04) |
| 2023 | $364.95 | 11 | AstraZeneca Pharmaceuticals LP ($108.48) |
| 2022 | $9,839 | 29 | Astellas Pharma US Inc ($8,827) |
| 2021 | $2,823 | 22 | Astellas Pharma US Inc ($1,973) |
| 2020 | $14,489 | 33 | Astellas Pharma US Inc ($13,524) |
| 2019 | $84,097 | 104 | Astellas Pharma US Inc ($83,035) |
| 2018 | $45,040 | 67 | Astellas Pharma US Inc ($44,296) |
| 2017 | $55,056 | 80 | Astellas Pharma US Inc ($53,691) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $24.04 | General |
| Category: Coronary | ||||||
| 10/15/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| Category: Cardiovascular | ||||||
| 12/21/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Cardiovascular | ||||||
| 10/20/2023 | Philips Electronics North America Corporation | (6342) Intrasight Integrated (Device) | Food and Beverage | Cash or cash equivalent | $63.42 | General |
| Category: Medical Device | ||||||
| 09/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $108.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.45 | General |
| Category: Cardiovascular | ||||||
| 08/24/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $26.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/13/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.32 | General |
| Category: Cardiovascular | ||||||
| 06/29/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/14/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $15.76 | General |
| Category: Coronary | ||||||
| 04/20/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.18 | General |
| Category: Cardiovascular | ||||||
| 01/12/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: Cardiovascular | ||||||
| 12/01/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/27/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Diabetes | ||||||
| 10/13/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: Cardiovascular | ||||||
| 10/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/05/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/14/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.68 | General |
| Category: Cardiovascular | ||||||
| 08/10/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 07/31/2022 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $4.93 | General |
| Category: Coronary | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 801 | 1,175 | $472,060 | $107,462 |
| 2022 | 13 | 798 | 1,114 | $466,850 | $102,825 |
| 2021 | 14 | 786 | 1,176 | $468,622 | $113,978 |
| 2020 | 10 | 619 | 941 | $259,580 | $74,364 |
Total Patients
3,004
Total Services
4,406
Medicare Billing
$398,628
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 403 | $88,660 | $38,552 | 43.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 66 | 66 | $165,000 | $23,815 | 14.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 133 | 139 | $111,200 | $20,266 | 18.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 64 | 64 | $32,640 | $8,903 | 27.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 21 | 84 | $12,600 | $3,558 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $8,710 | $2,831 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 152 | 229 | $10,763 | $2,419 | 22.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 67 | 69 | $26,800 | $2,248 | 8.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 11 | 11 | $5,720 | $1,708 | 29.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 28 | 28 | $5,320 | $1,410 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $2,100 | $934.79 | 44.5% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 16 | 16 | $1,312 | $468.21 | 35.7% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 13 | 13 | $715.00 | $223.86 | 31.3% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 13 | 13 | $520.00 | $125.72 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 352 | $77,440 | $33,074 | 42.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 73 | 73 | $182,500 | $26,887 | 14.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 119 | 121 | $96,800 | $17,878 | 18.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 61 | 62 | $31,620 | $8,538 | 27.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 21 | 84 | $12,600 | $4,064 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $7,035 | $2,642 | 37.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 18 | 20 | $10,263 | $2,553 | 24.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 163 | 241 | $11,327 | $2,504 | 22.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 72 | 73 | $28,800 | $1,891 | 6.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 27 | 27 | $5,130 | $1,389 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 14 | $2,100 | $1,037 | 49.4% |
About Dr. Kenneth Johnson, MD
Dr. Kenneth Johnson, MD is a Cardiovascular Disease healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588628739.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Johnson, MD has received a total of $211,787 in payments from pharmaceutical and medical device companies, with $77.87 received in 2024. These payments were reported across 350 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($176,595).
As a Medicare-enrolled provider, Johnson has provided services to 3,004 Medicare beneficiaries, totaling 4,406 services with total Medicare billing of $398,628. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology, Interventional Cardiology
- Location Dallas, TX
- Active Since 04/14/2006
- Last Updated 05/30/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1588628739
Products in Payments
- LEXISCAN (Drug) $48,784
- Lexiscan (Drug) $28,164
- VenaSeal (Device) $854.01
- HD-IVUS (Device) $589.00
- FFRct (Device) $493.49
- BRILINTA (Drug) $472.72
- FARXIGA (Drug) $432.40
- Micra (Device) $399.35
- CVI Systems (Device) $396.71
- ENTRESTO (Drug) $295.52
- Claria MRI (Device) $232.24
- LifeVest (Device) $219.56
- Corlanor (Drug) $168.60
- ELIQUIS (Drug) $165.57
- XARELTO (Drug) $163.00
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $142.51
- Vascepa (Drug) $115.84
- ClosureFast (Device) $107.58
- CAMZYOS (Drug) $86.38
- VERQUVO (Drug) $76.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Dallas
Darren Mcguire, Md, MD
Cardiovascular Disease — Payments: $2.0M
Cardiovascular Disease $2.0M
Dr. Peter Mccullough, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $1.3M
Cardiovascular Disease $1.3M
Robert Stoler, M.d, M.D
Cardiovascular Disease — Payments: $719,078
Cardiovascular Disease $719,078
Dr. Ann Navar, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $672,005
Cardiovascular Disease $672,005
Martin Berk, M.d, M.D
Cardiovascular Disease — Payments: $493,450
Cardiovascular Disease $493,450
James De Lemos, Md, MD
Cardiovascular Disease — Payments: $448,409
Cardiovascular Disease $448,409